You’ve cut down on salt, swapped crisps for nuts and even reined in the booze. Yet your blood pressure is still creeping upwards. Sound familiar?

Significantly lower risk of cardiometabolic and inflammation-associated clinical outcomes ...

Acute myeloid leukemia (AML) does more than infiltrate the lungs: it also transforms lung tissue to create an inflammatory ...

GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...

She began experiencing severe stomach aches, and the baby barfing turned into projectile vomiting. She also started to lose weight inexplicably. Knowing she needed to get help with her health, Lauren ...

New research links the 2024-2025 COVID-19 vaccine to fewer serious cardiovascular events among U.S. veterans, especially ...

FDA approved veligrotug-vvze for TED regardless of activity or duration, using a 12-week course of five IV infusions administered every three weeks. Pivotal THRIVE/THRIVE-2 trials met primary and all ...

Increasing the Ocrevus dose used in treating MS provided no additional benefit versus the approved regimen in trials with over 1,500 patients.

Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.

India must prioritize post-surgical pain management to enhance recovery outcomes and improve patients' quality of life.

Bupropion conferred modest reductions in cancer-related fatigue compared with placebo, according to results of a randomized ...

Veligrotug labeling shows data for both the active and chronic forms of TED ...